<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Antihistamine,Antihistamines,Major Drug Groups,Antihistamines,Major Drug Groups,5-HT receptor,ABT-239,ACE inhibitor,ATC code R06,Acetylcholine receptor,Acrivastine" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Antihistamine - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Antihistamine</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <p>An <b>antihistamine</b> is a <a href="../../../d/r/u/Drug.html" title="Drug">drug</a> which serves to reduce or eliminate effects mediated by <a href="../../../h/i/s/Histamine.html" title="Histamine">histamine</a>, an endogenous chemical mediator released during <a href="../../../a/l/l/Allergy.html" title="Allergy">allergic reactions</a>, through action at the <a href="../../../h/i/s/Histamine_receptor.html" title="Histamine receptor">histamine receptor</a>. Only agents where the main therapeutic effect is mediated by negative modulation of histamine receptors are termed antihistamines - other agents may have antihistaminergic action but are not true antihistamines.</p>
<p>In common use, the term antihistamine refers only to <b>H<sub>1</sub>-receptor antagonists</b>, also known as <b>H<sub>1</sub>-antihistamines</b>. It has been discovered that these H<sub>1</sub>-antihistamines are actually <a href="../../../i/n/v/Inverse_agonist.html" title="Inverse agonist">inverse agonists</a> at the histamine H<sub>1</sub>-receptor, rather than <a href="../../../r/e/c/Receptor_antagonist.html" title="Receptor antagonist">antagonists</a> <i>per se</i>. (Leurs, Church &amp; Taglialatela, 2002)</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Pharmacology"><span class="tocnumber">1</span> <span class="toctext">Pharmacology</span></a></li>
<li class="toclevel-1"><a href="#Clinical_use_of_antihistamines"><span class="tocnumber">2</span> <span class="toctext">Clinical use of antihistamines</span></a>
<ul>
<li class="toclevel-2"><a href="#Indications"><span class="tocnumber">2.1</span> <span class="toctext">Indications</span></a></li>
<li class="toclevel-2"><a href="#Adverse_drug_reactions"><span class="tocnumber">2.2</span> <span class="toctext">Adverse drug reactions</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#First-generation_H1-receptor_antagonists"><span class="tocnumber">3</span> <span class="toctext">First-generation H1-receptor antagonists</span></a>
<ul>
<li class="toclevel-2"><a href="#Ethylenediamines"><span class="tocnumber">3.1</span> <span class="toctext">Ethylenediamines</span></a></li>
<li class="toclevel-2"><a href="#Ethanolamines"><span class="tocnumber">3.2</span> <span class="toctext">Ethanolamines</span></a></li>
<li class="toclevel-2"><a href="#Alkylamines"><span class="tocnumber">3.3</span> <span class="toctext">Alkylamines</span></a></li>
<li class="toclevel-2"><a href="#Piperazines"><span class="tocnumber">3.4</span> <span class="toctext">Piperazines</span></a></li>
<li class="toclevel-2"><a href="#Tricyclics"><span class="tocnumber">3.5</span> <span class="toctext">Tricyclics</span></a></li>
<li class="toclevel-2"><a href="#Common_structural_features_of_classical_antihistamine"><span class="tocnumber">3.6</span> <span class="toctext">Common structural features of classical antihistamine</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Second-generation_H1-receptor_antagonists"><span class="tocnumber">4</span> <span class="toctext">Second-generation H1-receptor antagonists</span></a>
<ul>
<li class="toclevel-2"><a href="#Systemic"><span class="tocnumber">4.1</span> <span class="toctext">Systemic</span></a></li>
<li class="toclevel-2"><a href="#Topical"><span class="tocnumber">4.2</span> <span class="toctext">Topical</span></a></li>
<li class="toclevel-2"><a href="#Common_structural_features_of_non-sedating_antihistamines"><span class="tocnumber">4.3</span> <span class="toctext">Common structural features of non-sedating antihistamines</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Third-generation_H1-receptor_antagonists"><span class="tocnumber">5</span> <span class="toctext">Third-generation H1-receptor antagonists</span></a>
<ul>
<li class="toclevel-2"><a href="#Systemic_2"><span class="tocnumber">5.1</span> <span class="toctext">Systemic</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Other_agents"><span class="tocnumber">6</span> <span class="toctext">Other agents</span></a>
<ul>
<li class="toclevel-2"><a href="#Inhibitors_of_histamine_release"><span class="tocnumber">6.1</span> <span class="toctext">Inhibitors of histamine release</span></a></li>
<li class="toclevel-2"><a href="#H2-receptor_antagonists"><span class="tocnumber">6.2</span> <span class="toctext">H2-receptor antagonists</span></a></li>
<li class="toclevel-2"><a href="#H3-_and_H4-receptor_antagonists"><span class="tocnumber">6.3</span> <span class="toctext">H3- and H4-receptor antagonists</span></a>
<ul>
<li class="toclevel-3"><a href="#H3-receptors_antagonists"><span class="tocnumber">6.3.1</span> <span class="toctext">H3-receptors antagonists</span></a></li>
<li class="toclevel-3"><a href="#H4-receptors_antagonists"><span class="tocnumber">6.3.2</span> <span class="toctext">H4-receptors antagonists</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Other_agents_with_antihistaminergic_activity"><span class="tocnumber">6.4</span> <span class="toctext">Other agents with antihistaminergic activity</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">7</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Pharmacology" id="Pharmacology"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Pharmacology">edit</a>]</span> <span class="mw-headline">Pharmacology</span></h2>
<p>In allergic reactions an <a href="../../../a/l/l/Allergen.html" title="Allergen">allergen</a> (a type of <a href="../../../a/n/t/Antigen.html" title="Antigen">antigen</a>) interacts with and cross-links surface IgE <a href="../../../a/n/t/Antibody.html" title="Antibody">antibodies</a> on <a href="../../../m/a/s/Mast_cell.html" title="Mast cell">mast cells</a> and <a href="../../../b/a/s/Basophil.html" title="Basophil">basophils</a>. Once the mast cell-antibody-antigen complex is formed, a complex series of events occurs that eventually leads to cell-degranulation and the release of histamine (and other chemical mediators) from the mast cell or basophil. Once released, histamine can react with local or widespread tissues through <a href="../../../h/i/s/Histamine_receptor.html" title="Histamine receptor">histamine receptors</a>.</p>
<p>Histamine, acting on H<sub>1</sub>-receptors, produces <a href="../../../i/t/c/Itch.html" title="Itch">pruritus</a>, <a href="../../../v/a/s/Vasodilatation.html" title="Vasodilatation">vasodilatation</a>, <a href="../../../h/y/p/Hypotension.html" title="Hypotension">hypotension</a>, <a href="../../../f/l/u/Flushing_%28physiology%29.html" title="Flushing (physiology)">flushing</a>, <a href="../../../h/e/a/Headache.html" title="Headache">headache</a>, <a href="../../../t/a/c/Tachycardia.html" title="Tachycardia">tachycardia</a>, <a href="../../../b/r/o/Bronchoconstriction.html" title="Bronchoconstriction">bronchoconstriction</a>, increases <a href="../../../v/a/s/Vascular_permeability.html" title="Vascular permeability">vascular permeability</a>, potentiates <a href="../../../p/a/i/Pain_and_nociception.html" title="Pain and nociception">pain</a>, and more. (Simons, 2004)</p>
<p>While H<sub>1</sub>-antihistamines ameliorate these effects, they are only efficacious if administered prior to the allergen-challenge. In severe allergies, such as <a href="../../../a/n/a/Anaphylaxis.html" title="Anaphylaxis">anaphylaxis</a> or <a href="../../../a/n/g/Angioedema.html" title="Angioedema">angioedema</a>, these effects may be so severe as to be life-threatening. <a href="../../../e/p/i/Epinephrine.html" title="Epinephrine">Epinephrine</a>, often in the form of an autoinjector (<a href="../../../e/p/i/Epi-pen.html" title="Epi-pen">Epi-pen</a>), is required by people with such hypersensitivities.</p>
<p><a name="Clinical_use_of_antihistamines" id="Clinical_use_of_antihistamines"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Clinical use of antihistamines">edit</a>]</span> <span class="mw-headline">Clinical use of antihistamines</span></h2>
<p><a name="Indications" id="Indications"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Indications">edit</a>]</span> <span class="mw-headline">Indications</span></h3>
<p>H<sub>1</sub>-antihistamines are clinically used in the treatment of histamine-mediated allergic conditions. Specifically, these indications may include: (Rossi, 2004)</p>
<ul>
<li>allergic <a href="../../../r/h/i/Rhinitis.html" title="Rhinitis">rhinitis</a></li>
<li>allergic <a href="../../../c/o/n/Conjunctivitis.html" title="Conjunctivitis">conjunctivitis</a></li>
<li>allergic <a href="../../../s/k/i/Skin.html" title="Skin">dermatological</a> conditions (<a href="../../../c/o/n/Contact_dermatitis.html" title="Contact dermatitis">contact dermatitis</a>)</li>
<li><a href="../../../u/r/t/Urticaria.html" title="Urticaria">urticaria</a></li>
<li><a href="../../../a/n/g/Angioedema.html" title="Angioedema">angioedema</a></li>
<li><a href="../../../p/r/u/Pruritus.html" title="Pruritus">pruritus</a> (<a href="../../../a/t/o/Atopic_dermatitis.html" title="Atopic dermatitis">atopic dermatitis</a>, insect bites)</li>
<li><a href="../../../a/n/a/Anaphylaxis.html" title="Anaphylaxis">anaphylactic</a> or anaphylactoid reactions - adjunct only</li>
<li>nausea and vomiting (first-generation H<sub>1</sub>-antihistamines)</li>
<li>sedation (first-generation H<sub>1</sub>-antihistamines)</li>
</ul>
<p>Antihistamines can be administered topically (through the <a href="../../../s/k/i/Skin.html" title="Skin">skin</a>, <a href="../../../n/o/s/Nose.html" title="Nose">nose</a>, or <a href="../../../e/y/e/Eye.html" title="Eye">eyes</a>) or systemically, based on the nature of the allergic condition.</p>
<p>The authors of the American College of Chest Physicians Updates on Cough Guidelines (2006)recommend that for cough associated with the common cold, first-generation antihistamine-decongestants are more effective than newer, nonsedating antihistamines. First generation antihistamines include Diphenhydramine (Benadryl); Carbinoxamine (Clistin); Clemastine (Tavist);Chlorpheniramine (Chlor-Trimeton)and Brompheniramine (Dimetane).</p>
<p><br /></p>
<p><a name="Adverse_drug_reactions" id="Adverse_drug_reactions"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Adverse drug reactions">edit</a>]</span> <span class="mw-headline">Adverse drug reactions</span></h3>
<p><a href="../../../a/d/v/Adverse_drug_reaction.html" title="Adverse drug reaction">Adverse drug reactions</a> are most commonly associated with the first-generation H<sub>1</sub>-antihistamines. This is due to their relative lack of selectivity for the H<sub>1</sub>-receptor.</p>
<p>The most common adverse effect is sedation; this "side effect" is utilized in many <a href="../../../o/v/e/Over-the-counter_substance.html" title="Over-the-counter substance">OTC</a> sleeping-aid preparations. Other common adverse effects in first-generation H<sub>1</sub>-antihistamines include: dizziness, <a href="../../../t/i/n/Tinnitus.html" title="Tinnitus">tinnitus</a>, blurred vision, <a href="../../../e/u/p/Euphoria.html" title="Euphoria">euphoria</a>, uncoordination, <a href="../../../a/n/x/Anxiety.html" title="Anxiety">anxiety</a>, <a href="../../../i/n/s/Insomnia.html" title="Insomnia">insomnia</a>, tremor, <a href="../../../n/a/u/Nausea.html" title="Nausea">nausea</a> and vomiting, <a href="../../../c/o/n/Constipation.html" title="Constipation">constipation</a>, <a href="../../../d/i/a/Diarrhoea.html" title="Diarrhoea">diarrhoea</a>, dry mouth, and dry cough. Infrequent adverse effects include: urinary retention, <a href="../../../p/a/l/Palpitation.html" title="Palpitation">palpitations</a>, <a href="../../../h/y/p/Hypotension.html" title="Hypotension">hypotension</a>, <a href="../../../h/e/a/Headache.html" title="Headache">headache</a>, <a href="../../../h/a/l/Hallucination.html" title="Hallucination">hallucination</a>, and <a href="../../../p/s/y/Psychosis.html" title="Psychosis">psychosis</a>. (Rossi, 2004)</p>
<p>The newer second-generation H<sub>1</sub>-antihistamines are far more selective for peripheral histamine H<sub>1</sub>-receptors and, correspondingly, have a far improved tolerability profile compared to the first-generation agents. The most common adverse effects noted for second-generation agents include: drowsiness, fatigue, headache, nausea and dry mouth. (Rossi, 2004)</p>
<p><a name="First-generation_H1-receptor_antagonists" id="First-generation_H1-receptor_antagonists"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: First-generation H1-receptor antagonists">edit</a>]</span> <span class="mw-headline">First-generation H<sub>1</sub>-receptor antagonists</span></h2>
<p>These are the oldest antihistaminergic drugs and are relatively inexpensive and widely available. They are effective in the relief of allergic symptoms, but are typically moderately to highly potent muscarinic <a href="../../../a/c/e/Acetylcholine_receptor.html" title="Acetylcholine receptor">acetylcholine receptor</a>-antagonists (<a href="../../../a/n/t/Anticholinergic.html" title="Anticholinergic">anticholinergic</a>) agents as well. These agents also commonly have action at α-<a href="../../../a/d/r/Adrenergic_receptor.html" title="Adrenergic receptor">adrenergic receptors</a> and/or <a href="../../../5/-/h/5-HT_receptor_bebc.html" title="5-HT receptor">5-HT receptors</a>. This lack of receptor-selectivity is the basis of the poor tolerability-profile of some of these agents, especially compared with the second-generation H<sub>1</sub>-antihistamines. Patient response and occurrence of adverse drug reactions vary greatly between classes and between agents within classes.</p>
<p>The first H<sub>1</sub>-antihistamine discovered was piperoxan, by Jeff Forneau and <a href="../../../d/a/n/Daniel_Bovet_0f13.html" title="Daniel Bovet">Daniel Bovet</a> (1933) in their efforts to develop a <a href="../../../g/u/i/Guinea_pig.html" title="Guinea pig">guinea pig</a> animal-model for <a href="../../../a/n/a/Anaphylaxis.html" title="Anaphylaxis">anaphylaxis</a> at <a href="../../../r/y/e/Ryerson_University_318f.html" title="Ryerson University">Ryerson University</a>. Bovet went on to win the 1957 <a href="../../../n/o/b/Nobel_Prize_in_Physiology_or_Medicine_b5e4.html" title="Nobel Prize in Physiology or Medicine">Nobel Prize in Physiology or Medicine</a> for his contribution. Following their discovery, the first-generation H<sub>1</sub>-antihistamines were developed in the following decades. They can be classified on the basis of chemical structure, and agents within these groups have similar properties.</p>
<p><a name="Ethylenediamines" id="Ethylenediamines"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Ethylenediamines">edit</a>]</span> <span class="mw-headline">Ethylenediamines</span></h3>
<p>Ethylenediamines were the first group of clinically-effective H<sub>1</sub>-antihistamines developed.</p>
<ul>
<li><a href="../../../m/e/p/Mepyramine.html" title="Mepyramine">mepyramine</a> (pyrilamine)</li>
<li>antazoline</li>
</ul>
<p><a name="Ethanolamines" id="Ethanolamines"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Ethanolamines">edit</a>]</span> <span class="mw-headline">Ethanolamines</span></h3>
<p>Diphenhydramine was the prototypical agent in this group. Significant <a href="../../../a/n/t/Anticholinergic.html" title="Anticholinergic">anticholinergic</a> adverse effects, as well as sedation too, are observed in this group but the incidence of gastrointestnal adverse effects is relatively low. (Nelson, 2002; Rossi, 2004)</p>
<ul>
<li><a href="../../../d/i/p/Diphenhydramine.html" title="Diphenhydramine">diphenhydramine</a></li>
<li><a href="../../../c/a/r/Carbinoxamine.html" title="Carbinoxamine">carbinoxamine</a></li>
<li><a href="../../../d/o/x/Doxylamine.html" title="Doxylamine">doxylamine</a></li>
<li><a href="../../../c/l/e/Clemastine.html" title="Clemastine">clemastine</a></li>
<li><a href="../../../d/i/m/Dimenhydrinate.html" title="Dimenhydrinate">dimenhydrinate</a></li>
</ul>
<p><a name="Alkylamines" id="Alkylamines"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Alkylamines">edit</a>]</span> <span class="mw-headline">Alkylamines</span></h3>
<p>The <a href="../../../i/s/o/Isomer.html" title="Isomer">isomerism</a> is a significant factor in the activity of the agents in this group. <i>E</i>-triprolidine, for example, is 1000-fold more potent than <i>Z</i>-triprolidine. This difference relates to the positioning and fit of the molecules in the histamine H<sub>1</sub>-receptor binding site. (Nelson, 2002) Alkylamines are considered to have relatively fewer sedative and gastrointestinal adverse effects, but relatively greater incidence of paradoxical <a href="../../../c/e/n/Central_nervous_system.html" title="Central nervous system">CNS</a> stimulation. (Rossi, 2004)</p>
<ul>
<li><a href="../../../p/h/e/Pheniramine.html" title="Pheniramine">pheniramine</a></li>
<li><a href="../../../c/h/l/Chlorphenamine.html" title="Chlorphenamine">chlorphenamine</a> (chlorpheniramine)</li>
<li>dexchlorphenamine</li>
<li><a href="../../../b/r/o/Brompheniramine.html" title="Brompheniramine">brompheniramine</a></li>
<li><a href="../../../t/r/i/Triprolidine.html" title="Triprolidine">triprolidine</a></li>
</ul>
<p><a name="Piperazines" id="Piperazines"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Piperazines">edit</a>]</span> <span class="mw-headline">Piperazines</span></h3>
<p>These compounds are structurally-related to the ethylenediamines and the ethanolamines; and produce significant <a href="../../../a/n/t/Anticholinergic.html" title="Anticholinergic">anticholinergic</a> adverse effects. Compounds from this group are often used for motion sickness, vertigo, nausea and vomiting. The second-generation H<sub>1</sub>-antihistamine cetirizine also belongs to this chemical group. (Nelson, 2002)</p>
<ul>
<li><a href="../../../c/y/c/Cyclizine.html" title="Cyclizine">cyclizine</a></li>
<li><a href="../../../c/h/l/Chlorcyclizine.html" title="Chlorcyclizine">chlorcyclizine</a></li>
<li><a href="../../../h/y/d/Hydroxyzine.html" title="Hydroxyzine">hydroxyzine</a></li>
<li><a href="../../../m/e/c/Meclizine.html" title="Meclizine">meclizine</a></li>
</ul>
<p><a name="Tricyclics" id="Tricyclics"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Tricyclics">edit</a>]</span> <span class="mw-headline">Tricyclics</span></h3>
<p>These compounds differ from the <a href="../../../p/h/e/Phenothiazine.html" title="Phenothiazine">phenothiazine</a> <a href="../../../a/n/t/Antipsychotic.html" title="Antipsychotic">antipsychotics</a> in the ring-substitution and chain characteristics. (Nelson, 2002) They are also structurally-related to the <a href="../../../t/r/i/Tricyclic_antidepressant.html" title="Tricyclic antidepressant">tricyclic antidepressants</a>, explaining the antihistaminergic adverse effects of those two drug classes and also the poor tolerability profile of tricyclic H<sub>1</sub>-antihistamines. The second-generation H<sub>1</sub>-antihistamine loratadine was derived from compounds in this group.</p>
<ul>
<li><a href="../../../p/r/o/Promethazine.html" title="Promethazine">promethazine</a></li>
<li>alimemazine (trimeprazine)</li>
<li><a href="../../../c/y/p/Cyproheptadine.html" title="Cyproheptadine">cyproheptadine</a></li>
<li><a href="../../../a/z/a/Azatadine.html" title="Azatadine">azatadine</a></li>
<li><a href="../../../k/e/t/Ketotifen.html" title="Ketotifen">ketotifen</a></li>
</ul>
<p><a name="Common_structural_features_of_classical_antihistamine" id="Common_structural_features_of_classical_antihistamine"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Common structural features of classical antihistamine">edit</a>]</span> <span class="mw-headline">Common structural features of classical antihistamine</span></h3>
<ul>
<li>2 Aromatic rings, connected to a central Carbon, Nitrogen or CO</li>
<li>Spacer between the central X and the amine, usually 2-3 carbons in length, linear, ring, branched, saturated or unsaturated</li>
<li>Amine is substituted with small alkyl groups eg CH3</li>
</ul>
<p><a href="../../../a/n/t/Image%7EAntihistamine.jpg_2283.html" class="image" title="Image:Antihistamine.jpg"><img src="../../../upload/7/79/Antihistamine.jpg" alt="Image:Antihistamine.jpg" width="217" height="118" longdesc="../../../a/n/t/Image%7EAntihistamine.jpg_2283.html" /></a><br />
<b>X = N, R1 = R2 = small alkyl groups</b><br />
<b>X = C</b><br />
<b>X = CO</b></p>
<ul>
<li>Chirality at X can increase both the potency and selectivity for H1-receptors</li>
<li>For maximum potency, the two aromatic rings should be orientated in different planes.
<ul>
<li>for example, tricyclic ring system is slightly puckered and the two aromatic rings lie in different geometrical planes, giving the drug a very high potency.</li>
</ul>
</li>
</ul>
<p><a name="Second-generation_H1-receptor_antagonists" id="Second-generation_H1-receptor_antagonists"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Second-generation H1-receptor antagonists">edit</a>]</span> <span class="mw-headline">Second-generation H<sub>1</sub>-receptor antagonists</span></h2>
<p>These are newer drugs that are much more selective for peripheral H<sub>1</sub> receptors in preference to the <a href="../../../c/e/n/Central_nervous_system.html" title="Central nervous system">central nervous system</a> histaminergic and cholinergic receptors. This selectivity significantly reduces the occurrence of adverse drug reactions compared with first-generation agents, while still providing effective relief of allergic conditions.</p>
<p><a name="Systemic" id="Systemic"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Systemic">edit</a>]</span> <span class="mw-headline">Systemic</span></h3>
<ul>
<li><a href="../../../a/c/r/Acrivastine.html" title="Acrivastine">acrivastine</a></li>
<li><a href="../../../a/s/t/Astemizole.html" title="Astemizole">astemizole</a></li>
<li><a href="../../../c/e/t/Cetirizine.html" title="Cetirizine">cetirizine</a></li>
<li><a href="../../../l/o/r/Loratadine.html" title="Loratadine">loratadine</a></li>
<li>mizolastine</li>
<li><a href="../../../t/e/r/Terfenadine.html" title="Terfenadine">terfenadine</a> (withdrawn from most markets due to risk of <a href="../../../c/a/r/Cardiac_arrhythmia.html" title="Cardiac arrhythmia">cardiac arrhythmias</a> and replaced with <a href="../../../f/e/x/Fexofenadine.html" title="Fexofenadine">fexofenadine</a>)</li>
</ul>
<p><a name="Topical" id="Topical"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Topical">edit</a>]</span> <span class="mw-headline">Topical</span></h3>
<ul>
<li><a href="../../../a/z/e/Azelastine.html" title="Azelastine">azelastine</a></li>
<li><a href="../../../l/e/v/Levocabastine.html" title="Levocabastine">levocabastine</a></li>
<li><a href="../../../o/l/o/Olopatadine.html" title="Olopatadine">olopatadine</a></li>
</ul>
<p><a name="Common_structural_features_of_non-sedating_antihistamines" id="Common_structural_features_of_non-sedating_antihistamines"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Common structural features of non-sedating antihistamines">edit</a>]</span> <span class="mw-headline">Common structural features of non-sedating antihistamines</span></h3>
<p>Structure of these drugs varies from case to case. There is no common structural feature for the second generation H1-receptor antagonists.</p>
<p><a name="Third-generation_H1-receptor_antagonists" id="Third-generation_H1-receptor_antagonists"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Third-generation H1-receptor antagonists">edit</a>]</span> <span class="mw-headline">Third-generation H<sub>1</sub>-receptor antagonists</span></h2>
<p>These are the active <a href="../../../e/n/a/Enantiomer.html" title="Enantiomer">enantiomer</a> (levocetirizine) or <a href="../../../m/e/t/Metabolite.html" title="Metabolite">metabolite</a> (desloratadine &amp; fexofenadine) derivatives of second-generation drugs intended to have increased <a href="../../../e/f/f/Efficacy.html" title="Efficacy">efficacy</a> with fewer <a href="../../../a/d/v/Adverse_drug_reaction.html" title="Adverse drug reaction">adverse drug reactions</a>. Indeed, fexofenadine is associated with a decreased risk of <a href="../../../c/a/r/Cardiac_arrhythmia.html" title="Cardiac arrhythmia">cardiac arrhythmia</a> compared to terfenadine. However, there is little evidence for any advantage of levocetirizine or desloratadine, compared to <a href="../../../c/e/t/Cetirizine.html" title="Cetirizine">cetirizine</a> or <a href="../../../l/o/r/Loratadine.html" title="Loratadine">loratadine</a> respectively.</p>
<p><a name="Systemic_2" id="Systemic_2"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Systemic">edit</a>]</span> <span class="mw-headline">Systemic</span></h3>
<ul>
<li><a href="../../../l/e/v/Levocetirizine.html" title="Levocetirizine">levocetirizine</a></li>
<li><a href="../../../d/e/s/Desloratadine.html" title="Desloratadine">desloratadine</a></li>
<li><a href="../../../f/e/x/Fexofenadine.html" title="Fexofenadine">fexofenadine</a></li>
</ul>
<p><a name="Other_agents" id="Other_agents"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Other agents">edit</a>]</span> <span class="mw-headline">Other agents</span></h2>
<p><a name="Inhibitors_of_histamine_release" id="Inhibitors_of_histamine_release"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Inhibitors of histamine release">edit</a>]</span> <span class="mw-headline">Inhibitors of histamine release</span></h3>
<p>These agents appear to stabilise the mast cells to prevent degranulation and mediator release.</p>
<ul>
<li><a href="../../../c/r/o/Cromoglicate.html" title="Cromoglicate">cromoglicate</a> (cromolyn)</li>
<li><a href="../../../n/e/d/Nedocromil.html" title="Nedocromil">nedocromil</a></li>
</ul>
<p><a name="H2-receptor_antagonists" id="H2-receptor_antagonists"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: H2-receptor antagonists">edit</a>]</span> <span class="mw-headline">H<sub>2</sub>-receptor antagonists</span></h3>
<p><i>Main article: <a href="../../../h/2/-/H2-receptor_antagonist.html" title="H2-receptor antagonist">H2-receptor antagonist</a></i></p>
<p>Clinically-relevant histamine H<sub>2</sub>-receptors are found principally in the <a href="../../../p/a/r/Parietal_cell.html" title="Parietal cell">parietal cells</a> of the <a href="../../../s/t/o/Stomach.html" title="Stomach">gastric</a> mucosa. H<sub>2</sub>-receptor "antagonists" are also <a href="../../../i/n/v/Inverse_agonist.html" title="Inverse agonist">inverse agonists</a>, rather than true <a href="../../../r/e/c/Receptor_antagonist.html" title="Receptor antagonist">antagonists</a>; and are used to reduce the secretion of <a href="../../../g/a/s/Gastric_acid.html" title="Gastric acid">gastric acid</a>. Examples include <a href="../../../c/i/m/Cimetidine.html" title="Cimetidine">cimetidine</a>, <a href="../../../r/a/n/Ranitidine.html" title="Ranitidine">ranitidine</a>, and <a href="../../../f/a/m/Famotidine.html" title="Famotidine">famotidine</a>.</p>
<p><a name="H3-_and_H4-receptor_antagonists" id="H3-_and_H4-receptor_antagonists"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: H3- and H4-receptor antagonists">edit</a>]</span> <span class="mw-headline">H<sub>3</sub>- and H<sub>4</sub>-receptor antagonists</span></h3>
<p>These are experimental agents and do not yet have a defined clinical use.</p>
<p><a name="H3-receptors_antagonists" id="H3-receptors_antagonists"></a></p>
<h4><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: H3-receptors antagonists">edit</a>]</span> <span class="mw-headline">H<sub>3</sub>-receptors antagonists</span></h4>
<ul>
<li><a href="../../../a/b/t/ABT-239_bfca.html" title="ABT-239">ABT-239</a></li>
<li><a href="../../../t/h/i/Thioperamide.html" title="Thioperamide">Thioperamide</a></li>
<li><a href="../../../c/l/o/Clobenpropit.html" title="Clobenpropit">Clobenpropit</a></li>
<li><a href="../../../i/m/p/Impromidine.html" title="Impromidine">Impromidine</a>
<ul>
<li>
<ul>
<li>Similar in structure to <a href="../../../b/u/r/Burimamide.html" title="Burimamide">burimamide</a></li>
<li><a href="../../../i/m/i/Imidazole.html" title="Imidazole">imidazole</a> ring</li>
<li>Polar moiety on the <a href="../../../s/i/d/Side_chain.html" title="Side chain">side chain</a> - <a href="../../../t/h/i/Thiourea.html" title="Thiourea">thiourea</a>, isothiourea and <a href="../../../g/u/a/Guanidine.html" title="Guanidine">guanidine</a></li>
<li>other substituents are highly variable</li>
</ul>
</li>
</ul>
</li>
</ul>
<p><a name="H4-receptors_antagonists" id="H4-receptors_antagonists"></a></p>
<h4><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: H4-receptors antagonists">edit</a>]</span> <span class="mw-headline">H<sub>4</sub>-receptors antagonists</span></h4>
<ul>
<li><a href="../../../t/h/i/Thioperamide.html" title="Thioperamide">Thioperamide</a></li>
</ul>
<p><a name="Other_agents_with_antihistaminergic_activity" id="Other_agents_with_antihistaminergic_activity"></a></p>
<h3><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: Other agents with antihistaminergic activity">edit</a>]</span> <span class="mw-headline">Other agents with antihistaminergic activity</span></h3>
<p>Many drugs, used for other indications, possess unwanted antihistaminergic activity. These include <a href="../../../t/r/i/Tricyclic_antidepressants.html" title="Tricyclic antidepressants">tricyclic antidepressants</a>, <a href="../../../a/n/t/Antipsychotic.html" title="Antipsychotic">antipsychotics</a>, <i>etc</i>.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../h/2/-/H2-receptor_antagonist.html" title="H2-receptor antagonist">H2-receptor antagonist</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antihistamine.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ul>
<li>Forneau E, Bovet D (1933). Recherches sur l'action sympathicolytique d'un nouveau derive du dioxane. <i>Arch Int Pharmacodyn</i> <b>46</b>, 178-91.</li>
<li><cite style="font-style:normal">Leurs R, Church MK, Taglialatela M (2002). "H<sub>1</sub>-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects". <i>Clin Exp Allergy</i> <b>32</b> (4): 489-98. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11972592" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11972592">PMID 11972592</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=H%3Csub%3E1%3C%2Fsub%3E-antihistamines%3A+inverse+agonism%2C+anti-inflammatory+actions+and+cardiac+effects&amp;rft.title=Clin+Exp+Allergy&amp;rft.jtitle=Clin+Exp+Allergy&amp;rft.date=2002&amp;rft.volume=32&amp;rft.issue=4&amp;rft.au=Leurs+R%2C+Church+MK%2C+Taglialatela+M&amp;rft.pages=489-98">&#160;</span></li>
<li>Nelson, WL (2002). In Williams DA, Lemke TL (Eds.). <i>Foye's Principles of Medicinal Chemistry</i> (5 ed.). Philadelphia: Lippincott Williams &amp; Wilkins. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-683-30737-1</a></li>
<li>Rossi S (Ed.) (2004). <i><a href="../../../a/u/s/Australian_Medicines_Handbook_0c4c.html" title="Australian Medicines Handbook">Australian Medicines Handbook</a> 2004</i>. Adelaide: Australian Medicines Handbook. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-9578521-4-2</a></li>
<li><cite style="font-style:normal">Simons FE (2004, Nov 18). "Advances in H<sub>1</sub>-antihistamines". <i>N Engl J Med</i> <b>351</b> (21): 2203-17. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15548781" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15548781">PMID 15548781</a> <a href="http://content.nejm.org/cgi/content/extract/351/21/2203" class="external text" title="http://content.nejm.org/cgi/content/extract/351/21/2203" rel="nofollow">Abstract</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Advances+in+H%3Csub%3E1%3C%2Fsub%3E-antihistamines&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2004%2C+Nov+18&amp;rft.volume=351&amp;rft.issue=21&amp;rft.au=Simons+FE&amp;rft.pages=2203-17">&#160;</span></li>
</ul>
<table class="navbox collapsible autocollapse" style="margin: auto; text-align:left">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; text-align:left; width:6em;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../a/n/t/Template%7EAntihistamines_2a1c.html" title="Template:Antihistamines"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../a/n/t/Template_talk%7EAntihistamines_2c98.html" title="Template talk:Antihistamines"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../a/n/t/Template%7EAntihistamines_2a1c.html" class="external text" title="http://en.wikipedia.org../../../a/n/t/Template%7EAntihistamines_2a1c.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
<strong class="selflink">Antihistamines</strong> (primarily <a href="../../../a/t/c/ATC_code_R06_f31c.html" title="ATC code R06">R06</a>)</th>
</tr>
<tr>
<th style="">Aminoalkyl <a href="../../../e/t/h/Ethers.html" title="Ethers">ethers</a></th>
<td style="" colspan="1">Bromazine, <a href="../../../c/a/r/Carbinoxamine.html" title="Carbinoxamine">Carbinoxamine</a>, <a href="../../../c/l/e/Clemastine.html" title="Clemastine">Clemastine</a>, Chlorphenoxamine, <a href="../../../d/i/p/Diphenylpyraline.html" title="Diphenylpyraline">Diphenylpyraline</a>, <a href="../../../d/i/p/Diphenhydramine.html" title="Diphenhydramine">Diphenhydramine</a>, <a href="../../../d/o/x/Doxylamine.html" title="Doxylamine">Doxylamine</a></td>
</tr>
<tr>
<th style="">Substituted alkylamines</th>
<td style="" colspan="1"><a href="../../../b/r/o/Brompheniramine.html" title="Brompheniramine">Brompheniramine</a>, <a href="../../../c/h/l/Chlorphenamine.html" title="Chlorphenamine">Chlorphenamine</a>, <a href="../../../d/e/x/Dexbrompheniramine.html" title="Dexbrompheniramine">Dexbrompheniramine</a> , <a href="../../../d/e/x/Dexchlorpheniramine.html" title="Dexchlorpheniramine">Dexchlorpheniramine</a>, Dimetindene, <a href="../../../p/h/e/Pheniramine.html" title="Pheniramine">Pheniramine</a>, Talastine</td>
</tr>
<tr>
<th style="">Substituted <a href="../../../e/t/h/Ethylene_diamine.html" title="Ethylene diamine">ethylene diamines</a></th>
<td style="" colspan="1"><a href="../../../c/h/l/Chloropyramine.html" title="Chloropyramine">Chloropyramine</a>, Histapyrrodine, <a href="../../../m/e/p/Mepyramine.html" title="Mepyramine">Mepyramine</a>, <a href="../../../m/e/t/Methapyrilene.html" title="Methapyrilene">Methapyrilene</a>,<a href="../../../p/y/r/Pyribenzamine.html" title="Pyribenzamine">Pyribenzamine</a></td>
</tr>
<tr>
<th style=""><a href="../../../p/h/e/Phenothiazine.html" title="Phenothiazine">Phenothiazine</a> derivatives</th>
<td style="" colspan="1">Alimemazine, Hydroxyethylpromethazine, Isothipendyl, <a href="../../../m/e/q/Mequitazine.html" title="Mequitazine">Mequitazine</a>, <a href="../../../m/e/t/Methdilazine.html" title="Methdilazine">Methdilazine</a>, Oxomemazine, <a href="../../../p/r/o/Promethazine.html" title="Promethazine">Promethazine</a></td>
</tr>
<tr>
<th style=""><a href="../../../p/i/p/Piperazine.html" title="Piperazine">Piperazine</a> derivatives</th>
<td style="" colspan="1"><a href="../../../b/u/c/Buclizine.html" title="Buclizine">Buclizine</a>, <a href="../../../c/e/t/Cetirizine.html" title="Cetirizine">Cetirizine</a>, <a href="../../../c/h/l/Chlorcyclizine.html" title="Chlorcyclizine">Chlorcyclizine</a>, <a href="../../../c/i/n/Cinnarizine.html" title="Cinnarizine">Cinnarizine</a>, <a href="../../../c/y/c/Cyclizine.html" title="Cyclizine">Cyclizine</a>, <a href="../../../h/y/d/Hydroxyzine.html" title="Hydroxyzine">Hydroxyzine</a>, <a href="../../../l/e/v/Levocetirizine.html" title="Levocetirizine">Levocetirizine</a>, <a href="../../../m/e/c/Meclozine.html" title="Meclozine">Meclozine</a>, <a href="../../../n/i/a/Niaprazine.html" title="Niaprazine">Niaprazine</a>, <a href="../../../o/x/a/Oxatomide.html" title="Oxatomide">Oxatomide</a></td>
</tr>
<tr>
<th style="">Others for <a href="../../../s/y/s/Systemic.html" title="Systemic">systemic</a> use</th>
<td style="" colspan="1"><a href="../../../a/c/r/Acrivastine.html" title="Acrivastine">Acrivastine</a>, Antazoline, <a href="../../../a/s/t/Astemizole.html" title="Astemizole">Astemizole</a>, <a href="../../../a/z/a/Azatadine.html" title="Azatadine">Azatadine</a>, <a href="../../../a/z/e/Azelastine.html" title="Azelastine">Azelastine</a>, Bamipine, <a href="../../../c/y/p/Cyproheptadine.html" title="Cyproheptadine">Cyproheptadine</a>, Deptropine, <a href="../../../d/e/s/Desloratadine.html" title="Desloratadine">Desloratadine</a>, <a href="../../../e/b/a/Ebastine.html" title="Ebastine">Ebastine</a>, <a href="../../../e/p/i/Epinastine.html" title="Epinastine">Epinastine</a>, <a href="../../../k/e/t/Ketotifen.html" title="Ketotifen">Ketotifen</a>, <a href="../../../l/o/r/Loratadine.html" title="Loratadine">Loratadine</a>, <a href="../../../m/e/b/Mebhydrolin.html" title="Mebhydrolin">Mebhydrolin</a>, Mizolastine, Phenindamine, Pimethixene, Pyrrobutamine, <a href="../../../r/u/p/Rupatadine.html" title="Rupatadine">Rupatadine</a>, <a href="../../../t/e/r/Terfenadine.html" title="Terfenadine">Terfenadine</a>, <a href="../../../t/r/i/Triprolidine.html" title="Triprolidine">Triprolidine</a></td>
</tr>
<tr>
<th style="">For <a href="../../../t/o/p/Topical.html" title="Topical">topical</a> use</th>
<td style="" colspan="1">Bamipine, <a href="../../../c/h/l/Chloropyramine.html" title="Chloropyramine">Chloropyramine</a>, Chlorphenoxamine, <a href="../../../c/l/e/Clemastine.html" title="Clemastine">Clemastine</a>, Dimetindene, <a href="../../../d/i/p/Diphenhydramine.html" title="Diphenhydramine">Diphenhydramine</a>, Isothipendyl, <a href="../../../m/e/p/Mepyramine.html" title="Mepyramine">Mepyramine</a>, <a href="../../../p/r/o/Promethazine.html" title="Promethazine">Promethazine</a>, Thenalidine</td>
</tr>
<tr>
<th style=""><a href="../../../a/n/t/Antiallergic.html" title="Antiallergic">Antiallergic</a> agents excluding <a href="../../../c/o/r/Corticosteroids.html" title="Corticosteroids">corticosteroids</a></th>
<td style="" colspan="1">Antazoline, <a href="../../../a/z/e/Azelastine.html" title="Azelastine">Azelastine</a>, <a href="../../../f/e/x/Fexofenadine.html" title="Fexofenadine">Fexofenadine</a></td>
</tr>
<tr>
<th style="">Other antiallergics</th>
<td style="" colspan="1"><a href="../../../e/m/e/Emedastine.html" title="Emedastine">Emedastine</a>, <a href="../../../e/p/i/Epinastine.html" title="Epinastine">Epinastine</a>, <a href="../../../k/e/t/Ketotifen.html" title="Ketotifen">Ketotifen</a>, <a href="../../../o/l/o/Olopatadine.html" title="Olopatadine">Olopatadine</a></td>
</tr>
</table>
<table class="navbox collapsible autocollapse" style="margin: auto; text-align:left">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; text-align:left; width:6em;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" title="Template:Major Drug Groups"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../m/a/j/Template_talk%7EMajor_Drug_Groups_149b.html" title="Template talk:Major Drug Groups"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" class="external text" title="http://en.wikipedia.org../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
Major Drug Groups</th>
</tr>
<tr>
<th style=""><a href="../../../b/r/a/Brain.html" title="Brain">Brain</a> and <a href="../../../n/e/r/Nervous_system.html" title="Nervous system">Nervous system</a></th>
<td style="" colspan="1"><a href="../../../a/n/a/Analgesic.html" title="Analgesic">Analgesics</a>, <a href="../../../a/n/e/Anesthesia.html" title="Anesthesia">Anesthetics</a>, <a href="../../../a/n/x/Anxiolytic.html" title="Anxiolytic">Anxiolytics</a>, <a href="../../../a/n/t/Antidepressant.html" title="Antidepressant">Antidepressants</a>, <a href="../../../a/n/t/Antipsychotic.html" title="Antipsychotic">Antipsychotics</a>, <a href="../../../a/n/t/Anticonvulsant.html" title="Anticonvulsant">Anticonvulsants</a>, <a href="../../../s/t/i/Stimulant.html" title="Stimulant">Nervous system stimulants</a>, <a href="../../../a/n/t/Antiemetic.html" title="Antiemetic">Antiemetics</a>, <a href="../../../p/s/y/Psychedelics%2C_dissociatives_and_deliriants.html" title="Psychedelics, dissociatives and deliriants">Hallucinogens</a>, <a href="../../../m/o/o/Mood_stabilizer.html" title="Mood stabilizer">Mood stabilizers</a></td>
</tr>
<tr>
<th style=""><a href="../../../r/e/s/Respiratory_system.html" title="Respiratory system">Respiratory system</a></th>
<td style="" colspan="1"><a href="../../../b/r/o/Bronchodilator.html" title="Bronchodilator">Bronchodilators</a>, <a href="../../../d/e/c/Decongestant.html" title="Decongestant">Decongestants</a></td>
</tr>
<tr>
<th style=""><a href="../../../h/e/a/Heart.html" title="Heart">Heart</a> and <a href="../../../c/i/r/Circulatory_system.html" title="Circulatory system">Circulation</a></th>
<td style="" colspan="1"><a href="../../../a/c/e/ACE_inhibitor_fd43.html" title="ACE inhibitor">Angiotensin converting enzyme inhibitors</a>, <a href="../../../a/n/t/Antiarrhythmic_agent.html" title="Antiarrhythmic agent">Antiarrhythmics</a>, <a href="../../../a/n/t/Antianginal.html" title="Antianginal">Antianginals</a>, <a href="../../../a/n/t/Antihypertensive.html" title="Antihypertensive">Antihypertensives</a>, <a href="../../../h/y/p/Hypolipidemic_agent.html" title="Hypolipidemic agent">Antihyperlipidemics</a>, <a href="../../../a/n/t/Anticoagulant.html" title="Anticoagulant">Anticoagulants</a>, <a href="../../../a/n/t/Antiplatelet_drug.html" title="Antiplatelet drug">Antiplatelets</a>, <a href="../../../b/e/t/Beta_blocker.html" title="Beta blocker">Beta blockers</a>, <a href="../../../d/i/u/Diuretic.html" title="Diuretic">Diuretics</a>, <a href="../../../t/h/r/Thrombolytic_drug.html" title="Thrombolytic drug">Thrombolytics</a>, <a href="../../../v/a/s/Vasodilator.html" title="Vasodilator">Vasodilators</a></td>
</tr>
<tr>
<th style=""><a href="../../../g/a/s/Gastrointestinal_tract.html" title="Gastrointestinal tract">Gastrointestinal tract</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antacid.html" title="Antacid">Antacids</a>, <a href="../../../a/n/t/Antidiarrhoeal.html" title="Antidiarrhoeal">Antidiarrhoeals</a>, <a href="../../../h/2/-/H2-receptor_antagonist.html" title="H2-receptor antagonist">H2-receptor antagonists</a>, <a href="../../../p/r/o/Proton_pump_inhibitor.html" title="Proton pump inhibitor">Proton pump inhibitors</a>, <a href="../../../l/a/x/Laxative.html" title="Laxative">Laxatives</a></td>
</tr>
<tr>
<th style=""><a href="../../../m/u/s/Muscle.html" title="Muscle">Muscles</a>, <a href="../../../b/o/n/Bone.html" title="Bone">Bones</a>, and <a href="../../../j/o/i/Joint.html" title="Joint">Joints</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Anti-inflammatory.html" title="Anti-inflammatory">Anti-inflammatories</a>, <a href="../../../d/i/s/Disease-modifying_antirheumatic_drug.html" title="Disease-modifying antirheumatic drug">Antirheumatics</a>, <a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">Corticosteroids</a>, <a href="../../../m/u/s/Muscle_relaxant.html" title="Muscle relaxant">Muscle relaxants</a></td>
</tr>
<tr>
<th style=""><a href="../../../a/l/l/Allergy.html" title="Allergy">Allergy</a></th>
<td style="" colspan="1"><strong class="selflink">Antihistamines</strong></td>
</tr>
<tr>
<th style=""><a href="../../../i/n/f/Infection.html" title="Infection">Infections</a> and <a href="../../../i/n/f/Infestation.html" title="Infestation">Infestations</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antibiotic.html" title="Antibiotic">Antibiotics</a>, <a href="../../../a/n/t/Antiviral_drug.html" title="Antiviral drug">Antivirals</a>, <a href="../../../v/a/c/Vaccine.html" title="Vaccine">Vaccines</a>, <a href="../../../a/n/t/Antiprotozoal_agent.html" title="Antiprotozoal agent">Antiprotozoals</a>, <a href="../../../a/n/t/Antifungal_drug.html" title="Antifungal drug">Antifungals</a>, <a href="../../../a/n/t/Anthelmintic.html" title="Anthelmintic">Anthelmintics</a></td>
</tr>
<tr>
<th style=""><a href="../../../e/n/d/Endocrine_system.html" title="Endocrine system">Endocrine system</a></th>
<td style="" colspan="1"><a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">Corticosteroids</a>, <a href="../../../a/n/t/Anti-diabetic_drug.html" title="Anti-diabetic drug">Anti-diabetics</a></td>
</tr>
<tr>
<th style=""><a href="../../../m/a/l/Malignant.html" title="Malignant">Malignant</a> and <a href="../../../i/m/m/Immune_system.html" title="Immune system">Immune</a> disease</th>
<td style="" colspan="1"><a href="../../../c/h/e/Chemotherapy.html" title="Chemotherapy">Anticancer agents</a>, <a href="../../../i/m/m/Immunosuppressive_drug.html" title="Immunosuppressive drug">Immunosuppressants</a></td>
</tr>
<tr>
<th style=""><a href="../../../r/e/p/Reproductive_system.html" title="Reproductive system">Reproductive system</a></th>
<td style="" colspan="1"><a href="../../../h/o/r/Hormonal_contraception.html" title="Hormonal contraception">Hormonal contraception</a>, <a href="../../../f/e/r/Fertility_medication.html" title="Fertility medication">Fertility agents</a>, <a href="../../../s/e/l/Selective_estrogen_receptor_modulator.html" title="Selective estrogen receptor modulator">Selective estrogen receptor modulators</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/k/i/Skin.html" title="Skin">Skin</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antipruritic.html" title="Antipruritic">Antipruritics</a></td>
</tr>
</table>

<!-- 
Pre-expand include size: 36683 bytes
Post-expand include size: 23799 bytes
Template argument size: 13040 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/n/t/Antihistamine.html">http://en.wikipedia.org../../../a/n/t/Antihistamine.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Category</a>: <span dir='ltr'><a href="../../../a/n/t/Category%7EAntihistamines_6f5f.html" title="Category:Antihistamines">Antihistamines</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/n/t/Antihistamine.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/n/t/Talk%7EAntihistamine_5a2b.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Antihistamine">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../ca/a/n/t/Antihistam%C3%ADnic.html">Català</a>
	      </li>
	      	      <li>
	      <a href="../../../../da/a/n/t/Antihistamin.html">Dansk</a>
	      </li>
	      	      <li>
	      <a href="../../../../de/a/n/t/Antihistaminikum.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/a/n/t/Antihistam%C3%ADnico.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/a/n/t/Antihistaminique.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../it/a/n/t/Antistaminico.html">Italiano</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/a/n/t/Antihistaminicum.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E6%8A%97/%E3%83%92/%E3%82%B9/%E6%8A%97%E3%83%92%E3%82%B9%E3%82%BF%E3%83%9F%E3%83%B3%E8%96%AC.html">日本語</a>
	      </li>
	      	      <li>
	      <a href="../../../../sk/a/n/t/Antihistaminikum.html">Slovenčina</a>
	      </li>
	      	      <li>
	      <a href="../../../../fi/a/n/t/Antihistamiini.html">Suomi</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/a/n/t/Antihistamin.html">Svenska</a>
	      </li>
	      	      <li>
	      <a href="../../../../th/%E0%B8%AA/%E0%B8%B2/%E0%B8%A3/%E0%B8%AA%E0%B8%B2%E0%B8%A3%E0%B8%95%E0%B9%89%E0%B8%B2%E0%B8%99%E0%B8%AE%E0%B8%B4%E0%B8%AA%E0%B8%95%E0%B8%B2%E0%B8%A1%E0%B8%B5%E0%B8%99.html">ไทย</a>
	      </li>
	      	      <li>
	      <a href="../../../../tr/a/n/t/Antihistaminik.html">Türkçe</a>
	      </li>
	      	      <li>
	      <a href="../../../../uk/%D0%B0/%D0%BD/%D1%82/%D0%90%D0%BD%D1%82%D0%B8%D0%B3%D1%96%D1%81%D1%82%D0%B0%D0%BC%D1%96%D0%BD.html">Українська</a>
	      </li>
	      	      <li>
	      <a href="../../../../zh/%E6%8A%97/%E7%B5%84/%E7%B9%94/%E6%8A%97%E7%B5%84%E7%B9%94%E8%83%BA.html">中文</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 20:50, 13 March 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) <a href="../../../l/u/n/User%7ELuna_Santin_1cab.html" title="User:Luna Santin">Luna Santin</a>, Azulene, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../a/l/a/User%7EAlaibot_de3d.html" title="User:Alaibot">Alaibot</a>, <a href="../../../w/o/l/User%7EWolfmankurd_678f.html" title="User:Wolfmankurd">Wolfmankurd</a>, <a href="../../../t/h/i/User%7EThijs%21bot_bdf4.html" title="User:Thijs!bot">Thijs!bot</a>, <a href="../../../c/a/r/User%7ECarolfrog_505f.html" title="User:Carolfrog">Carolfrog</a>, <a href="../../../r/o/b/User%7ERobbot_3bd9.html" title="User:Robbot">Robbot</a>, <a href="../../../g/c/m/User%7EGcm_bb16.html" title="User:Gcm">Gcm</a>, <a href="../../../b/e/n/User%7EBenjaminevans82_7c6f.html" title="User:Benjaminevans82">Benjaminevans82</a>, <a href="../../../a/n/t/User%7EAntiVandalBot_aa84.html" title="User:AntiVandalBot">AntiVandalBot</a>, <a href="../../../j/d/f/User%7EJdforresterBot_2d17.html" title="User:JdforresterBot">JdforresterBot</a>, <a href="../../../k/a/i/User%7EKail_Ceannai_52b7.html" title="User:Kail Ceannai">Kail Ceannai</a>, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../t/e/c/User%7ETechelf_1565.html" title="User:Techelf">Techelf</a>, <a href="../../../c/a/p/User%7ECapecodeph_330c.html" title="User:Capecodeph">Capecodeph</a>, <a href="../../../p/s/e/User%7EPseudoSudo_e48d.html" title="User:PseudoSudo">PseudoSudo</a>, <a href="../../../d/s/1/User%7EDs13_da5c.html" title="User:Ds13">Ds13</a>, <a href="../../../g/i/l/User%7EGilliam_7bdc.html" title="User:Gilliam">Gilliam</a>, <a href="../../../b/r/h/User%7EBrholden_e08b.html" title="User:Brholden">Brholden</a>, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, <a href="../../../m/u/s/User%7EMushin_04d4.html" title="User:Mushin">Mushin</a>, <a href="../../../j/a/m/User%7EJames_McNally_d8fa.html" title="User:James McNally">James McNally</a>, <a href="../../../r/i/c/User%7ERichard_Slater_00cd.html" title="User:Richard Slater">Richard Slater</a>, <a href="../../../a/x/l/User%7EAxl_2118.html" title="User:Axl">Axl</a>, <a href="../../../d/b/t/User%7EDbtfz_4176.html" title="User:Dbtfz">Dbtfz</a>, <a href="../../../k/u/m/User%7EKummi_b4e9.html" title="User:Kummi">Kummi</a>, <a href="../../../s/t/r/User%7EStrabismus_60d0.html" title="User:Strabismus">Strabismus</a>, <a href="../../../c/a/n/User%7ECanthusus_6684.html" title="User:Canthusus">Canthusus</a>, <a href="../../../n/o/n/User%7ENongBot_a16b.html" title="User:NongBot">NongBot</a>, <a href="../../../h/e/d/User%7EHede2000_86f6.html" title="User:Hede2000">Hede2000</a>, Matijs van Zuijlen, <a href="../../../z/e/_/User%7EZe_miguel_0384.html" title="User:Ze miguel">Ze miguel</a>, <a href="../../../f/2/3/User%7EF23_7bb9.html" title="User:F23">F23</a>, <a href="../../../u/t/h/User%7EUthbrian_6843.html" title="User:Uthbrian">Uthbrian</a>, <a href="../../../g/r/e/User%7EGreatWhiteNortherner_ca92.html" title="User:GreatWhiteNortherner">GreatWhiteNortherner</a>, <a href="../../../r/o/b/User%7ERobyWayne_5f41.html" title="User:RobyWayne">RobyWayne</a>, <a href="../../../p/a/l/User%7EPalica_fbf7.html" title="User:Palica">Palica</a>, Allenmicky, <a href="../../../c/h/u/User%7EChupon_4a40.html" title="User:Chupon">Chupon</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../d/a/m/User%7EDamian_Yerrick_2a18.html" title="User:Damian Yerrick">Damian Yerrick</a>, <a href="../../../m/i/r/User%7EMiroku_Sanna_f283.html" title="User:Miroku Sanna">Miroku Sanna</a>, <a href="../../../j/e/r/User%7EJerryseinfeld_1f0e.html" title="User:Jerryseinfeld">Jerryseinfeld</a>, Schtigy, <a href="../../../s/a/y/User%7ESayeth_39df.html" title="User:Sayeth">Sayeth</a>, <a href="../../../a/r/m/User%7EArm_8860.html" title="User:Arm">Arm</a>, <a href="../../../j/t/n/User%7EJTN_e7f2.html" title="User:JTN">JTN</a>, <a href="../../../a/e/n/User%7EAenar_beed.html" title="User:Aenar">Aenar</a>, <a href="../../../d/a/e/User%7EDaevatgl_8f52.html" title="User:Daevatgl">Daevatgl</a>, Jerroleth, Carsonwaite, <a href="../../../j/i/a/User%7EJiang_5faa.html" title="User:Jiang">Jiang</a>, <a href="../../../d/i/b/User%7EDiberri_3d04.html" title="User:Diberri">Diberri</a>, <a href="../../../p/n/e/User%7EPne_05d6.html" title="User:Pne">Pne</a>, <a href="../../../n/a/d/User%7ENaddy_8480.html" title="User:Naddy">Naddy</a> and <a href="../../../s/n/o/User%7ESnoyes_3ec6.html" title="User:Snoyes">Snoyes</a>.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
